Singapore, Aug 9, 2010: Australian biomedical company, Tissue Therapies has received a patent for its “Skin Regeneration System” in Japan. This is the third in the family of core VitroGro patents, and the company has also received the Deed of Letters Patent.

This is in addition to the multiple VitroGro patents already granted in the US, South Korea, South Africa, Australia and New Zealand.

 

Dr Steven Mercer, CEO, Tissue Therapies said, “To have this patent granted in Japan is an excellent further step in consolidating the world wide IP position of VitroGro, particularly when Japan is one of the most important markets in East Asia. The examination process of the VitroGro patents in all international jurisdictions is progressing smoothly and I am hopeful that we will have more patent announcements before the end of 2010.”